Leadership

Visionary leaders. Defining the future of cancer detection.

Kiluma Biosciences is led by a multidisciplinary team of scientists, operators, clinicians, and innovators committed to advancing next-generation molecular diagnostics and transforming cancer detection through precision medicine.

Leadership Team

Scientific depth. Operational rigor.

Jenna Anderson

Co-Founder & Chief Executive Officer

Jenna Anderson is a healthcare executive and entrepreneur with extensive experience in operations, business development, strategic partnerships, and healthcare innovation. As CEO and Co-Founder of Kiluma Biosciences, she leads organizational growth, strategic initiatives, and execution of the company's mission to advance molecular diagnostics and oncology innovation.

Robert E. Mons III

Co-Founder & Chief Operating Officer

Robert Mons is a healthcare entrepreneur and executive with extensive experience building and scaling innovative healthcare and life science organizations. As Co-Founder and Chief Operating Officer of Kiluma Biosciences, he leads corporate strategy, business development, partnerships, fundraising, and commercialization initiatives. His focus is accelerating the development of next-generation diagnostic technologies capable of improving patient outcomes through earlier disease detection and precision medicine.

Dr. Clifford Morris

Chief Scientific Officer

Dr. Clifford Morris leads Kiluma's scientific strategy, biomarker discovery efforts, translational research initiatives, and clinical validation programs. His expertise spans molecular biology, genomics, biomarker development, and precision diagnostics. He oversees scientific collaborations and helps drive the advancement of Kiluma's oncology platform technologies.

Dr. Matthew R. Benson

Chief Medical Officer

Dr. Benson provides clinical leadership for Kiluma Biosciences and guides the development of clinically actionable diagnostic solutions. He works closely with healthcare providers, researchers, and clinical partners to ensure scientific rigor and real-world clinical relevance across the company's programs.

Dr. Ioan Cucoranu

Laboratory Director

Dr. Cucoranu oversees laboratory operations, quality systems, validation activities, and clinical testing infrastructure. He plays a critical role in ensuring the highest standards of laboratory excellence, compliance, and scientific integrity.

Dr. Marshall Jaroch

Director of Research & Development

Dr. Jaroch leads research and development initiatives supporting Kiluma's diagnostic platform. His work focuses on biomarker discovery, assay development, analytical validation, and advancing innovative approaches to molecular diagnostics and precision oncology.

Governance

Board of Directors

Kiluma Biosciences benefits from the guidance and strategic oversight of experienced leaders across healthcare, diagnostics, finance, entrepreneurship, and life sciences.

Scott Blum

Chairman of the Board

Scott Blum is an accomplished entrepreneur, investor, and business leader with decades of experience founding, building, and scaling innovative companies across e-commerce, consumer technology, and emerging growth industries. He has led organizations through multiple stages of expansion, capital formation, and market development, and has a long track record of identifying transformative opportunities and assembling the teams required to execute against them. As Chairman of the Board of Kiluma Biosciences, Scott provides strategic guidance, governance oversight, and executive mentorship, helping shape long-term corporate strategy, capital strategy, and commercialization planning as the company advances its precision diagnostics platform and oncology programs.

Parker Kelley

Board Member

Parker Kelley is a seasoned business executive and investor with significant experience in corporate finance, strategic growth, capital markets, and business development across both established and high-growth organizations. He has advised and helped scale companies through complex financing rounds, strategic partnerships, and operational expansion, with a focus on disciplined capital allocation and long-term value creation. As a member of the Board of Directors of Kiluma Biosciences, Parker contributes deep insight into corporate finance, investor engagement, governance, and strategic growth planning, supporting the company as it advances its precision diagnostics platform and brings next-generation oncology technologies toward commercialization.

Cameron Gray

Board Member

Cameron Gray is an experienced entrepreneur, investor, and strategic advisor with expertise in business growth, capital formation, corporate development, and emerging healthcare technologies. He has worked closely with innovative companies across multiple industries, helping organizations scale operations, establish strategic partnerships, and execute long-term growth initiatives. As a member of the Board of Directors, Cameron provides valuable insight into corporate strategy, business development, investor engagement, and organizational growth as Kiluma Biosciences advances its precision diagnostics platform and oncology initiatives.

Our Commitment

Transforming breakthrough science into clinical impact.

Kiluma Biosciences is committed to advancing the future of oncology through scientific innovation, collaborative research, and next-generation diagnostics designed to detect cancer earlier and improve patient outcomes. Our leadership team brings together expertise across healthcare, molecular diagnostics, laboratory medicine, research, and commercialization to transform breakthrough science into meaningful clinical impact.